New Delhi, May 24 -- India's drug pricing regulator is considering a proposal to cap trade margins of all medicines at 30% to curb profiteering, a proposal that the Narendra Modi-led government plans to implement if it retains power. The proposal has been discussed with the Prime Minister's Office, NITI Aayog and department of pharmaceuticals, a senior government official said on the condition of anonymity. It is part of the first 100-day agenda for the new government, the person said. If the proposal to cap trade margins on all drugs is implemented, it will be an expansion of the government's earlier scheme of restricting trade margins of cancer drugs. The National Pharmaceutical Pricing Authority (NPPA), while reducing the prices of cance...